ResearcherYonsei UniversityActive in the last 2 years
Chan Su Park
Matched on ORCID iD 0000-0003-1805-7382; OpenAlex author ID A5067465438. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 5
- Effects of Chemotherapy on Survival Outcomes in Older Patients with Metastatic Pancreatic Cancer: A Nationwide Population-Based Study. Co-author DOI 10.5009/gnl250551↗
- Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea. Cancers 2… Co-author DOI 10.3390/cancers17060963↗
- Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicenter observational study. Co-author DOI 10.1177/17588359241279688↗
- Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea. Co-author DOI 10.3390/cancers16183173↗
- Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective stud… Co-author DOI 10.3389/fonc.2023.1206565↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Byung Kyu Park · 3 shared papers, 2024–2026 · strength 1.00
- Paper Effects of Chemotherapy on Survival Outcomes in Older Patients with Metastatic Pancreatic Cancer: A Nationwide Populati… DOI 10.5009/gnl250551↗
- Paper Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Po… DOI 10.3390/cancers17060963↗
- Paper Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in … DOI 10.3390/cancers16183173↗
- Kyong Joo Lee · 3 shared papers, 2024–2026 · strength 1.00
- Paper Effects of Chemotherapy on Survival Outcomes in Older Patients with Metastatic Pancreatic Cancer: A Nationwide Populati… DOI 10.5009/gnl250551↗
- Paper Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Po… DOI 10.3390/cancers17060963↗
- Paper Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in … DOI 10.3390/cancers16183173↗
- Kang Ju Son · 3 shared papers, 2024–2026 · strength 1.00
- Paper Effects of Chemotherapy on Survival Outcomes in Older Patients with Metastatic Pancreatic Cancer: A Nationwide Populati… DOI 10.5009/gnl250551↗
- Paper Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Po… DOI 10.3390/cancers17060963↗
- Paper Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in … DOI 10.3390/cancers16183173↗
- Seung Woo Park · 2 shared papers, 2023–2024 · strength 0.34
- Paper Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicen… DOI 10.1177/17588359241279688↗
- Paper Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients wi… DOI 10.3389/fonc.2023.1206565↗
- Jung Hyun Jo · 2 shared papers, 2023–2024 · strength 0.34
- Paper Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicen… DOI 10.1177/17588359241279688↗
- Paper Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients wi… DOI 10.3389/fonc.2023.1206565↗
- Hee Seung Lee · 2 shared papers, 2023–2024 · strength 0.34
- Paper Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicen… DOI 10.1177/17588359241279688↗
- Paper Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients wi… DOI 10.3389/fonc.2023.1206565↗
- Moon Jae Chung · 2 shared papers, 2023–2024 · strength 0.34
- Paper Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicen… DOI 10.1177/17588359241279688↗
- Paper Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients wi… DOI 10.3389/fonc.2023.1206565↗
- Jeong Youp Park · 2 shared papers, 2023–2024 · strength 0.34
- Paper Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicen… DOI 10.1177/17588359241279688↗
- Paper Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients wi… DOI 10.3389/fonc.2023.1206565↗
- Seungmin Bang · 2 shared papers, 2023–2024 · strength 0.34
- Paper Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicen… DOI 10.1177/17588359241279688↗
- Paper Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients wi… DOI 10.3389/fonc.2023.1206565↗
- Jiyoung Keum · 1 shared paper, 2024 · strength 0.18
- Sang Hoon Lee · 1 shared paper, 2024 · strength 0.18
- Huapyong Kang · 1 shared paper, 2024 · strength 0.18
- Jae Hee Cho · 1 shared paper, 2024 · strength 0.18
- Sung Ill Jang · 1 shared paper, 2024 · strength 0.18
- Kyung In Shin · 1 shared paper, 2024 · strength 0.18
- Si Young Song · 1 shared paper, 2023 · strength 0.16
- Dawoon Jung · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.